About
Grab the opportunity to experience the noteworthy efficacy of VALCALM-250, an antiepileptic medication presented at competitive pricing. VALCALM-250 (Divalproex Sodium Extended Release Tablets, 250 mg) offers an unprecedented approach to managing seizure disorders, bipolar disorder, and migraine prophylaxis. Marketed and manufactured by Valience Healthcare Private Limited, this prescription-only medication comes in lustrous Alu-Alu blister packs (10x10 tablets) ensuring optimal integrity. Store in a cool, dry place below 25C to maintain product quality. Available for clinical and hospital use throughout India. Take advantage of this exceptional offer today!
Application Insights: VALCALM-250 Tablets
VALCALM-250 is designed for oral administration and is prescribed as a part of comprehensive treatment protocols in clinical and hospital settings. Its specific usage includes managing seizure disorders, stabilizing mood in bipolar disorder, and preventing migraines. The site of application is internal; tablets are swallowed whole rather than applied to any surface. This carefully formulated medication delivers consistent results when administered as directed by healthcare professionals.
Sampling and Payment Policies for VALCALM-250
For interested professionals, VALCALM-250 samples are available subject to drop-off at approved clinical sites. The sample policy aligns with industry standards, allowing practitioners to assess the product without initial expenditure. We offer flexible payment terms tailored to institutional needs, ensuring a seamless acquisition process. Take advantage of this opportunity to trial a leading antiepileptic therapy with the added benefit of an accommodating offer on payment and sampling.
FAQ's of VALCALM- 250:
Q: How should VALCALM-250 be stored to maintain its effectiveness?
A: To preserve its therapeutic potency, VALCALM-250 must be stored in a cool, dry place below 25C, away from moisture and direct sunlight.
Q: What is the process for obtaining samples of VALCALM-250?
A: Healthcare professionals interested in evaluating VALCALM-250 may request samples, which are drop-off enabled at authorized clinical sites, subject to our sample policy.
Q: When is VALCALM-250 indicated for use?
A: VALCALM-250 is indicated for the treatment of seizure disorders, bipolar disorder, and migraine prophylaxis as prescribed by a qualified healthcare provider.
Q: Where can VALCALM-250 be utilized?
A: This medication is intended for clinical and hospital environments under the supervision of licensed practitioners.
Q: What are the benefits of choosing VALCALM-250 over alternatives?
A: VALCALM-250 combines a lustrous formulation with competitive pricing, offering reliable efficacy in managing complex conditions and ensuring quality with alu-alu blister packaging.
Q: How should VALCALM-250 be administered?
A: The tablets are orally administered, swallowed whole, and should not be chewed or crushed to ensure extended-release effects.